| Felix Group Holdings Ltd (FLX) ORDINARY FULLY PAID |
Information Technology |
$15 |
SPP Booklet
|
26 Aug 2025 8:19AM |
$0.215 |
$0.050 |
fallen by
76.74%
|
|
| James Hardie Industries Plc (JHX) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$11,089 |
Participation At Upcoming Investor Conferences
|
26 Aug 2025 8:19AM |
$31.800 |
$34.850 |
risen by
9.59%
|
|
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$32 |
Up to 60% Anticorrosion Improvement in Water-Based Coatings
|
26 Aug 2025 8:19AM |
$0.145 |
$0.265 |
risen by
82.76%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Technologies Limited completed accelerated corrosion testing of its SPN additive in water-based coatings.
- SPN demonstrated up to 60% improvement in anticorrosion performance over control samples.
- Testing was conducted using salt spray fog tests with 2% SPN by weight.
- Water-based coatings typically perform below solvent-based coatings, making this improvement notable.
- SPN's performance offers an environmentally friendly solution in line with industry trends towards water-based products.
- Sparc is engaging with major global coatings manufacturers for further evaluation of SPN.
- The development represents a significant commercial milestone for Sparc Technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mammoth Minerals Limited (M79) ORDINARY FULLY PAID |
Materials |
$23 |
Exploration targeting Growth at Excelsior Au-Ag Project
|
26 Aug 2025 8:18AM |
$0.115 |
$0.042 |
fallen by
63.48%
|
|
M79 - Price-sensitive ASX Announcement
Full Release
Key Points
- Mammoth Minerals Limited is advancing exploration at its Excelsior Au-Ag Project in Western Australia.
- Recent geochemical and geophysical surveys have identified high-priority gold and silver targets.
- Exploration focuses on both extensions of known deposits and new, previously untested targets.
- Targets were identified using soil sampling, geological mapping, and reinterpretation of historical exploration data.
- Plans are underway for drill testing these targets as part of the next phase of exploration.
- The strategy aims to expand the project’s resource base and increase development potential.
- The company demonstrates a systematic, data-driven approach to exploration targeting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$112 |
Notification of buy-back - GEM
|
26 Aug 2025 8:18AM |
$0.915 |
$0.145 |
fallen by
84.15%
|
|
| Marimaca Copper Corp. (MC2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$322 |
Marimaca Announces MOD Feasibility Study
|
26 Aug 2025 8:18AM |
n/a |
$7.740 |
n/a
|
|
MC2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Marimaca Copper Corp. conducted a feasibility study for the MOD.
- Initial capital costs for 50 ktpa of copper production are estimated at $587 million.
- The project anticipates a copper production of 50 ktpa.
- Mining and processing costs are outlined, with detailed sustaining capital expenditures.
- Infrastructure plans include a BOOT model for water and power to minimize upfront costs.
- Additional deposits like Pampa Medina are explored for production optimization.
- Financial projections include EBITDA and NPV estimates.
- Metallurgical test work results are presented for process optimization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$112 |
Dividend/Distribution - GEM
|
26 Aug 2025 8:18AM |
$0.915 |
$0.145 |
fallen by
84.15%
|
|
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$112 |
CY25 Half Year ASX Announcement
|
26 Aug 2025 8:17AM |
$0.915 |
$0.145 |
fallen by
84.15%
|
|
GEM - Price-sensitive ASX Announcement
Full Release
Key Points
- CY23 saw strong occupancy growth and improved revenue for G8 Education Limited.
- Group occupancy and underlying profit increased compared to the previous period.
- Disciplined cost management and quality initiatives contributed to performance.
- Economic conditions such as labor shortages and regulatory changes impacted operations.
- Strategic investments and network optimization were priorities.
- Focus areas include staff retention, digital transformation, and quality enhancements.
- The company remains committed to sustainable growth and shareholder value.
- Financial and operational performance exceed prior period expectations.
- Outlook includes continued investment in quality and innovation.
- Regulatory and inflationary pressures remain ongoing sector challenges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$112 |
CY25 Half Year Investor Presentation
|
26 Aug 2025 8:17AM |
$0.915 |
$0.145 |
fallen by
84.15%
|
|
GEM - Price-sensitive ASX Announcement
Full Release
Key Points
- G8 Education Limited delivered solid financial performance for the half year ending 31 December 2023.
- Revenue growth driven by improved occupancy rates and disciplined cost control.
- Focus on centre quality improvement, employee experience enhancement, and digital enablement.
- Market environment remains challenging due to government policy changes, cost-of-living pressures, and sector supply dynamics.
- Investment priorities include quality education, workforce development, and technology adoption.
- G8 Education maintains a strong balance sheet and continues disciplined capital management, including dividend payments.
- Positive outlook for 2024 with continued growth expected from operational efficiency and investment in core business.
- Commitment to delivering value to shareholders, families, and communities through high-quality early learning services.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$112 |
Half Yearly Report and Accounts
|
26 Aug 2025 8:17AM |
$0.915 |
$0.145 |
fallen by
84.15%
|
|
GEM - Price-sensitive ASX Announcement
Full Release
Key Points
- G8 Education Limited (GEM) released its Half Yearly Report and Accounts for the six months ending 30 June 2023.
- Total revenue for the half year was $484.6 million, an increase from the previous year.
- Net profit after tax for the period was $26.2 million, which is higher compared to the prior corresponding period.
- Underlying EBIT for the half year was $54.0 million, reflecting improved operational performance.
- Occupancy rates increased, reaching an average of 71.3% for the half year.
- The company continued its focus on quality improvement through network investments and professional development.
- G8 Education maintained its commitment to sustainability, diversity, governance, and community engagement.
- The interim dividend declared for the period was 3.0 cents per share, fully franked.
- There were ongoing efforts to address workforce challenges, including staff recruitment and retention.
- G8 Education reported on its corporate governance practices and risk management framework.
- The financial position of the company remains strong, with cash and cash equivalents at $102.7 million as of 30 June 2023.
- The Board and management are confident in the company’s strategic direction and future outlook.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,685 |
Update - Notification of buy-back - ORA
|
26 Aug 2025 8:17AM |
$2.250 |
$1.375 |
fallen by
38.89%
|
|
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$154 |
Application for quotation of securities - NVX
|
26 Aug 2025 8:16AM |
$0.540 |
$0.155 |
fallen by
71.30%
|
|
| Capstone Copper Corp. (CSC) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$2,598 |
Capstone Copper Pinto Valley Site Awarded the Copper Mark
|
26 Aug 2025 8:16AM |
$10.830 |
$12.250 |
risen by
13.11%
|
|
| Tribeca Global Natural Resources Limited (TGF) ORDINARY FULLY PAID |
Financials |
$185 |
Appendix 4E and Annual Report
|
26 Aug 2025 8:16AM |
$1.455 |
$2.510 |
risen by
72.51%
|
|
TGF - Price-sensitive ASX Announcement
Full Release
Key Points
- Annual report covers the financial year ended 30 June 2023.
- TGF’s investment objective is to provide investors with absolute returns through exposure to the global natural resources sector.
- The company recorded a net profit after tax for the year.
- Net tangible asset backing per share and earnings per share figures are provided.
- A final fully franked dividend for the year was declared.
- The portfolio is actively managed with a combination of long and short positions focused on natural resources equities, derivatives, and debt instruments.
- The report details risk management strategies and exposure to market volatility.
- Auditor’s report confirms compliance with applicable accounting standards.
- Corporate governance policies, director remuneration, and management agreements are reviewed.
- Future outlook section comments on opportunities and risks in the natural resources sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$414 |
Dividend/Distribution - ACL
|
26 Aug 2025 8:16AM |
$2.500 |
$2.220 |
fallen by
11.20%
|
|
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,577 |
FY25 Appendix 4E
|
26 Aug 2025 8:16AM |
$8.350 |
$7.750 |
fallen by
7.19%
|
|
MAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 13% to $872.202 million.
- Profit from ordinary activities after tax attributable to members increased by 13%, totaling $57.147 million.
- Earnings per security (basic) increased by 12% to 28.35 cents per security.
- Net tangible assets per security (basic) increased by 28% to 97.81 cents.
- Interim dividend declared for the current period is 4.0¢, while the final dividend declared is 4.8¢.
- Ex-dividend date for the current period is 18 September 2025, with a record date of 19 September 2025, and payment date on 3 October 2025.
- Mader Group does not have a dividend reinvestment plan.
- No change in control of any entities during the current reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,577 |
FY25 Appendix 4E
|
26 Aug 2025 8:16AM |
$8.350 |
$7.750 |
fallen by
7.19%
|
|
MAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 13% to $872,202,000
- Profit after tax increased by 13% to $57,147,000
- Earnings per security increased to 28.35 cents
- Net tangible assets per security rose to 97.81 cents
- Interim and final dividends declared at 4.0 cents and 4.8 cents respectively
- No changes in control over entities during the reporting period
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$414 |
FY25 Results Presentation
|
26 Aug 2025 8:16AM |
$2.500 |
$2.220 |
fallen by
11.20%
|
|
ACL - Price-sensitive ASX Announcement
Full Release
Key Points
- ACL reported its financial results for FY25, including revenue, EBITDA, and NPAT figures.
- The company discussed the impact of Medicare changes and regulatory shifts on its operations.
- Cost optimization measures and strategic initiatives were highlighted to address market challenges.
- ACL continues to invest in technology and business integration to drive efficiency.
- Industry challenges such as inflation and supply chain issues were acknowledged and addressed.
- The company outlined growth opportunities and focus areas for margin improvement.
- The outlook for FY25 emphasizes leveraging scale and delivering shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Motio Ltd (MXO) ORDINARY FULLY PAID |
Communication Services |
$17 |
Letter to Shareholders - Notice of Annual General Meeting
|
26 Aug 2025 8:16AM |
$0.053 |
$0.053 |
fallen by
0%
|
|
| Motio Ltd (MXO) ORDINARY FULLY PAID |
Communication Services |
$17 |
Notice of Annual General Meeting/Proxy Form
|
26 Aug 2025 8:15AM |
$0.053 |
$0.053 |
fallen by
0%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$414 |
FY25 Results Announcement
|
26 Aug 2025 8:15AM |
$2.500 |
$2.220 |
fallen by
11.20%
|
|
ACL - Price-sensitive ASX Announcement
Full Release
Key Points
- ACL reported its financial results for FY25, detailing revenue and profit figures.
- The company faced challenges from market conditions and regulatory changes impacting the pathology sector.
- ACL implemented cost management and efficiency initiatives to address rising operational costs.
- Investment in digital transformation and technology upgrades was a key strategic focus.
- The company maintained its commitment to service quality and clinical excellence.
- Dividend policy and capital management strategies were outlined in the announcement.
- ACL continues to prioritize growth opportunities and shareholder value.
- The report included an outlook on future performance and industry trends.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$414 |
Appendix 4E and Financial Report 30 June 2025
|
26 Aug 2025 8:15AM |
$2.500 |
$2.220 |
fallen by
11.20%
|
|
ACL - Price-sensitive ASX Announcement
Full Release
Key Points
- Australian Clinical Labs Limited reported for the financial year ended 30 June 2025.
- Statutory revenue, profit before tax, and net profit after tax decreased compared to the prior year, primarily due to a reduction in COVID-19 testing.
- Core pathology operations remained stable, with slight growth in non-COVID-19 revenue.
- Dividend was declared and details of payment provided, reflecting ongoing shareholder returns.
- Significant investment in digital transformation, automation, and laboratory information systems to drive efficiency and innovation.
- Strategic focus on cost control, operational efficiency, and disciplined acquisition-led growth.
- Governance structure, board composition, and risk management frameworks described in detail.
- Remuneration report outlines executive performance incentives and alignment with company objectives.
- Financial statements include comprehensive notes on accounting policies, segment performance, and capital management.
- Auditor’s and directors’ declarations confirm compliance with statutory obligations and assurance of financial integrity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Felix Group Holdings Ltd (FLX) ORDINARY FULLY PAID |
Information Technology |
$15 |
Shareholder Letter - SPP
|
26 Aug 2025 8:15AM |
$0.215 |
$0.050 |
fallen by
76.74%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$55,760 |
FY25 Full Year Results Presentation
|
26 Aug 2025 8:15AM |
$20.000 |
$18.110 |
fallen by
9.45%
|
|
FMG - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue: US$15.5 billion
- Underlying EBITDA: US$7.9 billion
- Net profit after tax: US$3.4 billion
- Free cash flow: US$2.6 billion
- Final dividend: A$0.60 per share
- Total dividend payout: 65% of NPAT
- Net zero emissions target by 2040
- Iron Bridge project shipped 7.1Mt
- Gross debt to EBITDA: <2x
- Gross gearing: 21%
- Strong innovation and technology initiatives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$55,760 |
FY25 Full Year Results Presentation
|
26 Aug 2025 8:15AM |
$20.000 |
$18.110 |
fallen by
9.45%
|
|
FMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Fortescue Metals Group (FMG) reported strong FY25 financial results with a total revenue of US$15.5 billion.
- The company achieved an underlying EBITDA of US$7.9 billion and a net profit after tax (NPAT) of US$3.4 billion.
- Total iron ore shipments ranged between 195 to 205 million tonnes, with a C1 cost of US$17.50 to US$18.50 per wet metric tonne.
- FY25 dividends were declared at A$3.4 billion, representing a 65% payout ratio.
- FMG is committed to achieving a 'Real Zero' target by eliminating Scope 1 and 2 emissions from its Australian operations by 2030.
- The company is also focusing on decarbonisation, deploying electric heavy mobile equipment, and expanding solar farms.
- FMG's capital expenditure for FY25 was noted at US$3.9 billion, with future guidance ranging from US$3.6 to US$4.3 billion.
- FMG aims to maintain a strong balance sheet with a gross debt to EBITDA ratio not exceeding 2x.
- There is a significant focus on sustainability and diversification, including the Iron Bridge project and expanding into renewable energy solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
